Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1227.95 19.10 (1.58%) | NSE 1222.50 12.30 (1.02%) | Trade | Add

BSE Live

Nov 14, 16:01

1227.95 19.10 (1.58%)

Volume

AVERAGE VOLUME

5-Day

62,059

10-Day

70,026

30-Day

46,388

49,980

Prev. Close

1208.85
Open Price

1210.05

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Nov 14, 15:59

1222.50 12.30 (1.02%)

Volume

AVERAGE VOLUME

5-Day

1,646,750

10-Day

1,816,597

30-Day

1,377,933

2,055,973

Prev. Close

1210.20
Open Price

1210.20

Bid Price (Qty.)
1222.50 (562)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Aurobindo Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	12,195.24	8,197.85	5,928.64	4,648.12	4,429.31
Less: Excise/Sevice Tax/Other Levies	152.01	159.37	145.51	97.56	99.50
Revenue From Operations [Net]	12,043.23	8,038.48	5,783.13	4,550.56	4,329.81
Total Operating Revenues	12,120.52	8,099.79	5,855.32	4,627.40	4,381.48
Other Income	96.71	23.24	28.54	24.70	71.41
Total Revenue	12,217.23	8,123.03	5,883.86	4,652.10	4,452.89
EXPENSES
Cost Of Materials Consumed	4,122.81	3,518.27	3,091.44	2,225.51	2,241.84
Purchase Of Stock-In Trade	1,712.27	184.97	169.58	300.31	137.60
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-329.48	-102.00	-270.25	-6.06	-206.42
Employee Benefit Expenses	1,302.26	831.92	663.31	535.69	425.07
Finance Costs	159.87	310.16	266.64	277.24	64.65
Depreciation And Amortisation Expenses	332.61	312.53	248.74	200.53	171.50
Other Expenses	2,749.04	1,534.66	1,340.29	1,010.65	820.13
Total Expenses	10,049.38	6,590.51	5,509.75	4,543.87	3,654.37
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	2,167.85	1,532.52	374.11	108.23	798.52
Exceptional Items	0.00	0.00	0.00	-321.18	-10.34
Profit/Loss Before Tax	2,167.85	1,532.52	374.11	-212.95	788.18
Tax Expenses-Continued Operations
Current Tax	596.53	350.64	136.64	14.79	197.21
Less: MAT Credit Entitlement	9.95	124.56	126.50	0.00	0.00
Deferred Tax	-4.22	137.37	64.16	-121.55	26.72
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	596.59	363.45	82.71	-88.81	225.12
Profit/Loss After Tax And Before ExtraOrdinary Items	1,571.26	1,169.07	291.40	-124.14	563.06
Profit/Loss From Continuing Operations	1,571.26	1,169.07	291.40	-124.14	563.06
Profit/Loss For The Period	1,571.26	1,169.07	291.40	-124.14	563.06
Minority Interest	4.51	3.78	2.46	0.64	0.39
Consolidated Profit/Loss After MI And Associates	1,575.77	1,172.85	293.86	-123.50	563.45
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	54.00	40.00	10.00	-4.00	20.00
Diluted EPS (Rs.)	54.00	40.00	10.00	-4.00	18.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	131.28	87.41	43.68	29.11	58.72
Tax On Dividend	25.04	14.85	7.20	4.72	9.64